Brief: Pearsanta Submits Application Seeking To Advance Clinical Trials For Mitomic Prostate Test, Targeting Early Detection In High-Risk Patients
04/09/2024 13:55
Sept 4 (Reuters) - Aditxt Inc ADTX.O :
* ADITXT SUBSIDIARY PEARSANTA SUBMITS A GRANT APPLICATION
SEEKING
TO ADVANCE CLINICAL TRIALS FOR MITOMIC® PROSTATE TEST, TARGETING
EARLY DETECTION IN HIGH-RISK PATIENTS
Source text for Eikon: ID:nBw2P07GJa
Further company coverage: ADTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aditxt
See all newsBrief: Ignite Proteomics Announces 10,000-Patient Oncology Registry For Therapy Selection
Brief: Aditxt Appoints Jeffrey M. Busch As Interim CEO; Founder And Former CEO Of $1B NYSE Enterprise Which Delivered ~8.5% Dividends To Shareholders
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM